More Success for CAR T-Cell Therapy in Rheumatic Disease
Stunning improvement for two patients with rare form of autoimmune myositis
Stay updated with breaking news from Georg Schett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stunning improvement for two patients with rare form of autoimmune myositis
In patients with systemic lupus erythematous, CAR T-cell therapy appears to be a feasible and effective method of achieving durable remission, according to a speaker at the Biologic Therapies Summit.“Lupus patients often need quite substantial amounts of glucocorticoids to stay in remission, and that is a huge problem,” Georg Schett, MD, of Friedrich-Alexander University, in Germany,
Corporate Presentation MAY 2023 © 2023 Cabaletta Bio. All rights reserved. ... | May 1, 2023
An appellant's burden on appeal is never easy but it is particularly difficult when the questions at issue are based on factual evidence. The appellate judiciary is loathe (generally)...
16.03.2023 - – Company expecting Investigational New Drug (IND) clearance in the first half of 2023 for CABA-201, a 4-1BB-containing fully human CD19-CAR T cell therapy, with potential to generate initial clinical data by the first half of 2024 – PHILADELPHIA, ...